【摘 要】
：
Background: Tumor-induced osteomalacia (TIO), or oncogenic osteomalacia, is a rare paraneoplastic syndrome attributed to tumor overproduction of FGF23, increasing renal phosphate excretion and seconda
【机 构】
：
Metabolic Bone Disease and Genetic Research Unit, Department of Osteoporosis and Related Bone Diseas
【出 处】
：
第七届国际骨质疏松及骨矿盐疾病学术会议
论文部分内容阅读
Background: Tumor-induced osteomalacia (TIO), or oncogenic osteomalacia, is a rare paraneoplastic syndrome attributed to tumor overproduction of FGF23, increasing renal phosphate excretion and secondary hypophosphatemia.Clinical signs include bone pain, proximal muscle weakness and pathological fractures.
其他文献
Background: Dysregulated miRNAs in osteoclasts caused osteoclasts dysfunction contributing to skeletal disorders and modulating dysregulated miRNA in osteoclasts could regulate their dysfunction.But t
Background: Metabolic skeletal disorders associated with impaired bone formation (e.g., osteoporosis) are still major clinical challenges.RNAi provides a promising approach to address the challenges.H
Background: Lung cancer is the major cause of malignancyrelated death worldwide.Metastases account for 90％ of lung cancer deaths, and frequently target the skeleton and lead to rapid deterioration in
Background: Annulus fibrosus (AF) regeneration is critical to intervertebral disc repair, yet remains challenging due to the remarkable heterogeneity of AF tissue.Since the stiffness of substrate dete
Background: Patients underwent hematopoietic stem cell transplantation (HSCT) experience rapid bone loss after HSCT.The magnitude of fractures and the risk factors remain unknown.
伴随着人口老化的不断加剧,骨质疏松症已成为一个严重影响大众健康的问题而引起社会的广泛关注.据统计我国现有骨质疏松症患者约9千万人,骨量减少者约6千万人,每年因骨质疏松而导致骨折的发病率呈逐年上升的态势,给社会和家庭造成巨大的经济负担.因而预防和治疗骨质疏松性骨折就显得尤为重要.
骨转换是新近认识的骨强度重要决定因素,它能影响骨质量构成的每个因素.骨转换过程可以通过生化标志反映出来,间接显示成骨细胞与破骨细胞的活性.骨转换指标是反映骨骼细胞活性与骨基质代谢水平的生化产物,通常分为骨形成标志物和骨吸收标志物两类,前者代表成骨细胞活性及骨形成状态,后者主要反应破骨细胞活性与骨吸收水平.
Background: To explore the efficacy and safety of lμg alfacalcidol daily in Chinese postmenopausal women with osteoporosis or osteopenia.Methods: In this open-label and uncontrolled clinical trial,62
Background: Presently, researches about the intravenous calcium suppression test (CST) have been mainly focusing on the diagnosis of primary hyperparathyroidism (PHPT) but rarely on other types.Theref
Tendinopathy at advanced stages often manifests degenerative changes in tendons.The tendon disease affects millions of Americans each year in both occupational and athletic settings.In general, it is